borderline significancep = 0.086
Serum VCA-IgA ≥1:160 was also related to lower CR rate with borderline significance (47.6%, 10/21 vs 67.3%, 70/104, p = 0.086).
Serum VCA-IgA ≥1:160 was also related to lower CR rate with borderline significance (47.6%, 10/21 vs 67.3%, 70/104, p = 0.086).
Patients with pretreatment serum VCA-IgA ≥1:160 also seemed to have higher relapse rate (60.0%, 6/10 vs 34.3%, 24/70), but the difference did not reach statistical significance ( p = 0.164).